There is no fulltext present in this item.

Find Full text  
Title: Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs
Author(s): Zuur, M.A.; Pasipanodya, J.G.; Soolingen, D. van ; Werf, T.S. van der; Gumbo, T.; Alffenaar, J.W.C.
Publication year: 2018
Source: Clinical Infectious Diseases, vol. 67, iss. 11, (2018), pp. 1743-1749
ISSN: 1058-4838
DOI: https://doi.org/10.1093/cid/ciy346
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/199484   http://hdl.handle.net/2066/199484

Display more details
Subject: All institutes and research themes of the Radboud University Medical Center
Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences
Organization: Medical Microbiology
Journal title:
Clinical Infectious Diseases
Volume: vol. 67
Issue: iss. 11
Page start: p. 1743
Page end: p. 1749

This item appears in the following Collection(s)

Browse

Statistics